Juvenile Polyps in Bangladeshi Children and Their Association with Fecal Calprotectin as a Biomarker

다국어 초록 (Multilingual Abstract)

Purpose: Colonoscopy is considered the most reliable method for the diagnosis of juvenile polyps. However, colonoscopic screening is an invasive and expensive procedure. Fecal calprotectin (FCP), a marker of intestinal inflammation, has been shown to be elevated in patients with polyps. Therefore, this study aimed to evaluate FCP as a screening biomarker for the diagnosis of juvenile polyps.
Methods: This cross-sectional, observational study was conducted at the Pediatric Gastroenterology and Nutrition Department, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh. For children with polyps, colonoscopic polypectomy and histopathology were performed. FCP levels were analyzed before and 4 weeks after polypectomy in all patients. Information was recorded in a datasheet and analyzed using the computer-based program SPSS.
Results: The age of the children was between 2.5 and 12 years. Approximately 93% of the polyps were found in the rectosigmoid region. Children with juvenile polyps had elevated levels of FCP before polypectomy that subsequently normalized after polypectomy. The mean FCP levels before and after polypectomy were 277±247 μg/g (range, 80–1,000 μg/g) and 48.57±38.23 μg/g (range, 29–140 μg/g) (p<0.001), respectively. The FCP levels were significantly higher in patients with multiple polyps than in those with single polyps. Moreover, mean FCP levels in patients with single and multiple polyps were 207.6±172.4 μg/ g and 515.4±320.5 μg/g (p<0.001), respectively.
Conclusion: Colonic juvenile polyps were found to be associated with elevated levels of FCP that normalized after polypectomy. Therefore, FCP may be recommended as a noninvasive screening biomarker for diagnosis of colonic juvenile polyps.

참고문헌 (Reference)

1 Olafsdottir I, "Value of fecal calprotectin as a biomarker for juvenile polyps in children investigated with colonoscopy" 62 : 43-46, 2016

2 McMahon CW, "The role of fecal calprotectin in investigating digestive disorders" 3 : 19-, 2018

3 Vaos G, "The role of calprotectin in pediatric disease" 2013 : 542363-, 2013

4 Mestre JR, "The changing pattern of juvenile polyps" 81 : 312-314, 1986

5 Montalto M, "Role of fecal calprotectin in gastrointestinal disorders" 17 : 1569-1582, 2013

6 Costa F, "Role of faecal calprotectin as non-invasive marker of intestinal inflammation" 35 : 642-647, 2003

7 박재홍, "Role of colonoscopy in the diagnosis and treatment of pediatric lower gastrointestinal disorders" 대한소아청소년과학회 53 (53): 824-829, 2010

8 Latt TT, "Rectal bleeding and polyps" 69 : 144-147, 1993

9 Gelb AM, "Rectal and colonic polyps occurring in young people" 62 : 513-518, 1962

10 Vrabie R, "Noninvasive markers of disease activity in inflammatory bowel disease" 10 : 576-584, 2014

11 Voganatsi A, "Mechanism of extracellular release of human neutrophil calprotectin complex" 70 : 130-134, 2001

12 Thakkar KH, "M1575 : the frequency and determinants of polyps in children : results from a national endoscopic database" 71 : AB258-, 2010

13 Fox VL, "Juvenile polyps : recurrence in patients with multiple and solitary polyps" 8 : 795-799, 2010

14 Mandhan P, "Juvenile colorectal polyps in children : experience in Pakistan" 20 : 339-342, 2004

15 Ko FY, "Intestinal polyps in children and adolescents--a review of 103 cases" 36 : 197-202, 1995

16 Yachha SK, "Gastrointestinal bleeding in children" 11 : 903-907, 1996

17 Johne B, "Functional and clinical aspects of the myelomonocyte protein calprotectin" 50 : 113-123, 1997

18 Pezzilli R, "Fecal calprotectin levels in patients with colonic polyposis" 53 : 47-51, 2008

19 Teitelbaum JE, "Fecal calprotectin in juvenile polyposis coli" 44 : 593-, 2010

20 Khan F, "Fecal calprotectin as a future screening tool for large juvenile polyps" 2 : 2015

21 Pauley-Hunter RJ, "Fecal calprotectin and pediatric juvenile polyps" 60 : 30-31, 2015

22 Di Nardo G, "Faecal calprotectin and ultrasonography as non-invasive screening tools for detecting colorectal polyps in children with sporadic rectal bleeding : a prospective study" 46 : 66-, 2020

23 Poullis A, "Emerging role of calprotectin in gastroenterology" 18 : 756-762, 2003

24 Bjerke K, "Distribution of macrophages and granulocytes expressing L1 protein(calprotectin)in human Peyer’s patches compared with normal ileal lamina propria and mesenteric lymph nodes" 34 : 1357-1363, 1993

25 Cynamon HA, "Diagnosis and management of colonic polyps in children" 114 : 593-596, 1989

26 Wei C, "Colorectal polyps in children : a retrospective study of clinical features and the value of ultrasonography in their diagnosis" 47 : 1853-1858, 2012

27 Giardiello FM, "Colorectal neoplasia in juvenile polyposis or juvenile polyps" 66 : 971-975, 1991

28 Holgersen LO, "Colonoscopy for rectal bleeding in childhood" 13 : 83-85, 1978

29 Pillai RB, "Colonic polyps in children: frequently multiple and recurrent" 37 : 253-257, 1998

30 Poddar U, "Colonic polyps : experience of 236 Indian children" 93 : 619-622, 1998

31 Rathi C, "Clinical, endoscopic, and pathologic characteristics of colorectal polyps in Indian children and adolescents" 34 : 453-457, 2015

32 Røseth AG, "Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study" 27 : 793-798, 1992

33 Steinbakk M, "Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin" 336 : 763-765, 1990

34 Fagerhol MK, "A radioimmunoassay for a granulocyte protein as a marker in studies on the turnover of such cells" 16 : 273-282, 1980